| 1 |
Noh J, Choi WS, Noh G, et al. Presence of Foxp3-expressing CD19 (+)CD5 (+)B cells in human peripheral blood mononuclear cells: human CD19 (+) CD5 (+) Foxp3 (+) regulatory B cell(Breg) [J]. Immune Netw, 2010, 10(6):247-249.
|
| 2 |
Wolf SD, Dittel BN, Hardardottir F, et al. Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice[J]. J Exp Med, 1996.184(6):2271-2278.
|
| 3 |
Watanabe R, Fujimoto M, Ishiura N, et al. CD19 expression in B cells is important for suppression of contact hypersensitivity [J]. Am J Pathol, 2007, 171(2):560-570.
|
| 4 |
Mauri C. Ehrenstein MR. The short history of regulatory B cells [J]. Trend Immunol, 2008, 29(1):34-40.
|
| 5 |
den Haan JM, Kraal G, Bevan MJ, et al. Lipopolysaccharide induces IL-10-producing regulatory CD4+ T cells that suppress the CD8+ T cell response [J]. J Immunol, 2007, 178(9):5429-5433.
|
| 6 |
Goode I, Xu H, Ildstad ST. Regulatory B cells: the new "it" cell [J]. Transplant Proc, 2014, 46(1):3-8.
|
| 7 |
Ding Q, Yeung M, Camirand G, et al. Regulatory B cells are identified by expression of TIM-1 and can be induced through TIM-1 ligation to promote tolerance in mice [J]. J Clin Invest, 2011, 121(9):3645-3656.
|
| 8 |
Matsushita T, Horikawa M, Iwata Y, et al. Regulatory B cells(B10 cells) and regulatory T cells have independent roles in controlling experimental autoimmune encephalomyelitis initiation and late-phase immunopathogenesis [J]. Immunol, 2010, 185(4):2240-2252.
|
| 9 |
Wong SC, Puaux AL, Chittezhath M, et al. Macrophage polarization to a unique phenotype driven by B cells [J]. Eur J Immunol, 2010, 40(8):2296-2307.
|
| 10 |
Mizoguchi E, Mizoguchi A, Preffer FI, et al. Regulatory role of mature B cells in a murine model of inflammatory bowel disease [J]. Int Immunol, 2000, 12(5):597-605.
|
| 11 |
Carter NA, Vaseoncellos R, Rosser EC, et al. Micelacking endogenous IL-10-producing regulatory B cells develop exacerbated disease and present with all increased frequency of Thl/Th17 but a decrease in regulatory T cells [J]. J Immanol, 2011, 186(10):5569-5579.
|
| 12 |
Lemoine S, Morva A, Youinou P, et al. Regulatory B cells in autoimmune diseases: how do they work? [J]. Ann NY Acad Sci, 2009, 1173(2):260-267.
|
| 13 |
Yin Z, Bahtiyar G, Zhang N, et al. IL-10 regulates murine lupus [J]. Immunol, 2002, 169(4):2148-2155.
|
| 14 |
Watanabe R, Ishiura N, Nakashima H, et al. Regulatory B cells (B10 cells) have a suppressive role in murine lupus: CD19 and B10 cell deficiency exacerbates systemic autoimmunity [J]. J Immunol, 2010, 184(9):4801-4809.
|
| 15 |
Gao NL, Dresel J, Eckstein V, et al. Impaired suppressive capacity of activation-induced regulatory B cells in systemic lupus erythematosus [J]. Arthritis Rheumatol, 2014. (In press)
|
| 16 |
Amano H, Amano E, Moll T, et al. The Yaa mutation promoting murine lupus causes defective development of marginal zone B cells [J]. J Immunol, 2003, 170(5):2293-2301.
|
| 17 |
Blair PA, Norena LY, Flores-Booa F, et al. CD19+CD24hiCD38hiB cells exhibit regulatory capacity in healthy Individuals but are functionally impaired in systemic lupus erythematosus patients [J]. Immunity, 2010, 32(1):129-140.
|
| 18 |
Iwata Y, Matsushita T, Horikawa M, et al. Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells[J]. Blood, 2011, 117(2):530-541.
|
| 19 |
Evans JG, Chavez-Rueda KA, Eddaoudi A, et al. Novel suppressive function of transitional 2 B cells in experimental arthritis [J]. J Immunol, 2007, 178(12):7868-7878.
|
| 20 |
Ioannis K, Ayumi Y, Thomas FT. IL-10-producing regulatory B cells (BIO cells) in autoimmune disease [J]. Arthritis R & T, 2013, 15(Suppl 1):S1.
|
| 21 |
Carter NA, Vasconcellos R, Rosser EC, et al. Mice lacking endogenous IL-10-producing regulatory B cells develop exacerbated disease and present with an increased frequency of Th1/Th17 but a decrease in regulatory T cells [J]. J Immunol, 2011, 186(10):5569-5579.
|
| 22 |
Flores-Borja F, Bosma A, Nq D, et al. CD19+CD24hiCD38hiB cells maintain regulatory T cells while limiting TH1 and TH17 differentiation. [J]. Sci Transl Med, 2013.5(173):ra23.
|
| 23 |
Kirkland D, Benson A, Mirpuri J, et al. B cell-intrinsic MyD88 signaling prevents the lethal dissemination of commensal bacteria during colonic damage[J]. Immunity, 2012, 36(2):228-238.
|
| 24 |
Klinker MW, Lundy SK. Multiple mechanisms of immune suppression by B lymphocytes[J]. Mol Med, 2012, 18(1):123-137.
|
| 25 |
Hussain S, Delovitch TL. Intravenous transfusion of BCR-activated B cells protects NOD mice from type 1 diabetes in an IL-10-dependent manner[J]. J Immunol, 2007, 179(11):7225-7232.
|
| 26 |
Mizoguchi A, Mizoguchi E, Smith RN, et al. Suppressive role of B cells in chronic colitis of T cell receptor alpha mutant mice[J]. J Exp Med, 1997, 186(10):1749-1756.
|
| 27 |
Wei B, Velazquez P, Turovskaya O, et al. Mesenteric B cells centrally inhibit CD4+ T cell colitis through interaction with regulatory T cell subsets[J]. Proc Natl Acad Sci USA, 2005, 102(6):2010-2015.
|
| 28 |
Klinker MW, Lundy SK. Multiple mechanisms of immune suppression by B lymphocytes[J]. Mol Med, 2012, 18(1):123-137.
|
| 29 |
Wang RX, Yu CR, Dambuza IM, et al. Interleukin-35 induces regulatory B cells that suppress autoimmune disease [J]. Nat Med, 2014, 20(6):633-641.
|